Primary prostate cancers with ERG fusions are associated with decreased prostate‐specific membrane antigen expression and uptake on prostate‐specific membrane antigen positron emission tomography imaging
Cancer · 01.12.2026 · 132 (23)
DOI: 10.1002/cncr.70675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 18.11.2026. Verfasst von Oluwademilade Dairo und 19 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Congressionally Directed Medical Research Programs.
Abstract (Originalsprache)
Background
Although prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) imaging is increasingly standard for prostate tumor staging at diagnosis, the molecular correlates of PSMA expression are underexplored.
Methods
Digitally quantified PSMA protein expression was correlated with clinical‐pathologic, immune microenvironment, and molecular features of primary tumors, including those with paired pelvic lymph node metastases. The association of primary tumor ERG fusion status with radiotracer uptake was tested in three clinical trials of initial staging 18 F‐DCFPyL PSMA PET imaging. The association of ERG status with PSMA PET sensitivity for pelvic lymph node metastasis was examined in men undergoing initial PET staging.
Results
Primary tumor PSMA expression did not vary by self‐identified race or genetic ancestry and was negatively correlated with tumor T‐ and B‐lymphocyte densities. Primary tumors with ERG fusions expressed less PSMA than those without, but this association was not maintained for pelvic lymph node metastases. ERG fusion‐positive primary tumors had lower maximum standardized uptake values compared to ERG fusion‐negative tumors in two of three clinical trials. Among pN1 patients with preoperative imaging, the sensitivity of PSMA PET for nodal metastases was not significantly different by ERG status, although this study was limited by its retrospective and correlative nature.
Conclusions
PSMA PET primary tumor visualization may be limited by lower expression of PSMA in tumors with ERG fusions, with implications for PET‐based primary tumor staging. However, there is no evidence for decreased PSMA expression—or altered sensitivity of PSMA PET—in lymph node metastases from ERG fusion‐positive tumors.
Förderung
- Congressionally Directed Medical Research Programs
Zitieren
APA
Dairo, O., Voter, A. F., Pepra‐Ameyaw, P., Konchou, M. M., Khandhedia, R., Novaes, R. F., Xie, S., Lu, J., Amaral, A., Gomes‐Alexandre, C., Allaf, M. E., Gorin, M. A., Pomper, M. G., Savas, H., Schaeffer, E. M., Weiner, A. B., Joshu, C., Rowe, S. P., Marzo, A. M. D., & Lotan, T. L. (2026). Primary prostate cancers with ERG fusions are associated with decreased prostate‐specific membrane antigen expression and uptake on prostate‐specific membrane antigen positron emission tomography imaging. Cancer, 132(23). https://doi.org/10.1002/cncr.70675
Vancouver
Dairo O, Voter AF, Pepra‐Ameyaw P, Konchou MM, Khandhedia R, Novaes RF, et al. Primary prostate cancers with ERG fusions are associated with decreased prostate‐specific membrane antigen expression and uptake on prostate‐specific membrane antigen positron emission tomography imaging. Cancer. 2026;132(23). doi:10.1002/cncr.70675
BibTeX
@article{Dairo2026,
author = {Dairo, Oluwademilade and Voter, Andrew F. and Pepra‐Ameyaw, Patience and Konchou, Morelle Meegane and Khandhedia, Riya and Novaes, Ruana Farias and Xie, Sean and Lu, Jiayun and Amaral, Adrianna and Gomes‐Alexandre, Carolina and Allaf, Mohamad E. and Gorin, Michael A. and Pomper, Martin G. and Savas, Hatice and Schaeffer, Edward M. and Weiner, Adam B. and Joshu, Corinne and Rowe, Steven P. and Marzo, Angelo M. De and Lotan, Tamara L.},
title = {Primary prostate cancers with ERG fusions are associated with decreased prostate‐specific membrane antigen expression and uptake on prostate‐specific membrane antigen positron emission tomography imaging},
journal = {Cancer},
year = {2026},
volume = {132},
number = {23},
doi = {10.1002/cncr.70675}
}
EUVIMED